Virtu Financial’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $80K | Buy |
35,136
+23,339
| +198% | +$53.1K | ﹤0.01% | 1064 |
|
|
2025
Q1 | $8K | Sell |
11,797
-45,215
| -79% | -$30.7K | ﹤0.01% | 1205 |
|
|
2024
Q4 | $59K | Sell |
57,012
-31,506
| -36% | -$32.6K | ﹤0.01% | 1129 |
|
|
2024
Q3 | $104K | Buy |
+88,518
| New | +$104K | 0.01% | 901 |
|
|
2023
Q2 | – | Sell |
-24,136
| Closed | -$36K | – | 1603 |
|
|
2023
Q1 | $36K | Buy |
+24,136
| New | +$36K | ﹤0.01% | 1151 |
|
|
2022
Q1 | – | Sell |
-52,434
| Closed | -$227K | – | 1594 |
|
|
2021
Q4 | $227K | Buy |
+52,434
| New | +$227K | 0.02% | 773 |
|
|
2021
Q1 | – | Sell |
-14,051
| Closed | -$92K | – | 1663 |
|
|
2020
Q4 | $92K | Buy |
14,051
+986
| +8% | +$6.46K | 0.01% | 1083 |
|
|
2020
Q3 | $87K | Buy |
+13,065
| New | +$87K | 0.01% | 733 |
|
|
2018
Q2 | – | Sell |
-11,123
| Closed | -$316K | – | 2044 |
|
|
2018
Q1 | $316K | Buy |
+11,123
| New | +$316K | 0.02% | 1015 |
|
|
2017
Q4 | – | Sell |
-12,291
| Closed | -$223K | – | 2435 |
|
|
2017
Q3 | $223K | Buy |
+12,291
| New | +$223K | 0.01% | 1717 |
|